Today's Top Health News Story

Exclusive: Malaria champions unnerved by Trump uncertainty at crucial time

DAVOS, Switzerland, Jan 20 (Reuters)- When it comes to fighting malaria, Bill Gates and Ray Chambers are both inspired and concerned: With victory in sight, will the world's new leaders commit to finally beating this persistent parasite? Learn More

 

More Top Health Stories

U.S. governors want Congress to keep funding health benefits for poor

WASHINGTON (Reuters) - U.S. Republican governors on Thursday urged Washington lawmakers to keep funding health benefits for millions of low-income Americans, even as Congress is working to repeal Obamacare, President Barack Obama's landmark health insurance law. More »

 

Pharma CEOs in Davos put brave face on Trump presidency

DAVOS, Switzerland (Reuters) - Leaders of the global pharmaceutical industry, blasted by incoming U.S. President Donald Trump for "getting away with murder" on drug prices, are putting a brave face on the challenges in their biggest market. More »

 

U.S. judge delays Texas plan to cut Planned Parenthood funding

AUSTIN, Texas (Reuters) - A U.S. judge issued a temporary restraining on Thursday halting Texas' plan to cut Medicaid funding for Planned Parenthood to give him more time to consider thousands of pages of documents filed in the politically charged case, court records showed. More »

 

U.S. health agency tells Grassley there is no EpiPen deal yet

NEW YORK (Reuters) - Mylan NV has yet to reach a settlement with the U.S. Department of Justice over the classification in the Medicaid program of its life-saving EpiPen allergy treatment, according to a letter from a regulatory agency disclosed on Thursday. More »

 

Seeing e-cigarettes may boost desire to smoke

(Reuters Health) - - Newer versions of e-cigarettes known as vape pens may not look much like traditional cigarettes, but seeing someone use these devices still sparks a desire to smoke, a recent study suggests. More »

 

Bristol won't seek faster Opdivo/Yervoy lung cancer approval

(Reuters) - Bristol-Myers Squibb Co on Thursday said it has decided not to seek accelerated U.S. approval for a combination of its two immunotherapy drugs as an initial treatment for lung cancer. More »

 

EpiPen rival to be offered free to many but high price for insurers

(Reuters) - Privately held drugmaker Kaleo on Thursday said it would offer its Auvi-Q emergency allergy auto-injector at no cost to many consumers, but set a list price for the EpiPen rival that will be used as the benchmark cost to insurance companies at a whopping $4,500. More »

 

Merck CEO sees Keytruda in pole position in cancer race

DAVOS, Switzerland (Reuters) - Merck & Co's Keytruda cancer drug, which last week won a speedy review from U.S. regulators for use with chemotherapy in lung cancer, is in an increasingly strong position in a fiercely competitive market, the company's CEO said on Thursday. More »

 

Olympic athletes have heart problems, too

(Reuters Health) - Some Olympic athletes could be at risk while training and competing because of heart defects or dysfunction that they may not even know about, Italian researchers say. More »

 

News, Photo and Web Search